Cal-Maine (NASDAQ:CALM) Reports Sales Below Analyst Estimates In Q3 CY2026 Earnings, Stock Drops

Cal-Maine Foods (CALM) reported Q3 2026 revenue of $539.6M, down 41.5% YoY, missing estimates. GAAP loss of $1.26 per share was 63.1% below consensus. Management cited market rebalancing and investment in growth areas. Stock dropped 6% post-earnings.

Original reporting
Published Sep 30, 2026, 10:06 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 2:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cal-Maine (NASDAQ:CALM) Reports Sales Below Analyst Estimates In Q3 CY2026 Earnings, Stock Drops — source image
Decision brief

The 30-second read

$CALMBearishHigh
01

Why it matters

The earnings miss highlights ongoing weakness in the conventional shell egg market and raises concerns about demand recovery.

02

Market read

The miss adds downside pressure to the consumer staples space and may influence short‑term sentiment on related agribusiness stocks.

03

What to watch

Strong balance sheet and planned capacity growth could support a turnaround later in fiscal 2028.

Relevance 8/10Novelty 8/10Timing: after-hours reaction

Background

Cal-Maine Foods is the largest U.S. egg producer, and its earnings release is a key data point for the consumer staples sector.

Company-level read

Ticker impact

$CALMBearishMedium confidence
Context

Cal-Maine reported Q3 2026 earnings with revenue down 41.5% YoY and a GAAP loss of $1.26 per share, missing analyst estimates and causing the stock to drop 6% after the release.

Expected impact

likely further downside as investors price in weaker revenue and earnings.

Evidence & confidence

The miss is material for a mid‑cap consumer staple; the stock already fell 6% on the news and no mitigating guidance was provided.

Market effects

Egg and broader consumer staples sector may see pressure if other peers report similar demand weakness.

U.S. consumer staple indices could be modestly weighed down.

Limited to U.S. markets; no immediate global ripple.

Counterpoint

If the company can successfully expand its prepared foods capacity, the current dip may present a buying opportunity.

Key entities

  • Cal-Maine Foods

    U.S. egg producer reporting Q3 2026 earnings.

Related articles

$LQDAMed

Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more

Rogers rose 10% on higher earnings guidance ($3.80 vs. $3.65 consensus). Liquidia fell 25% after a patent infringement ruling, while United Therapeutics gained 15%. Jabil dropped 7% despite beating earnings and revenue estimates. Concentrix climbed 5% on strong earnings but issued weak guidance. Moderna fell 7% after a Citi downgrade. FormFactor gained 8% on a Deutsche Bank buy rating. Cal-Maine Foods declined 2% on a wider-than-expected loss.

$CALMMedAI 8/10

Maine Foods Q1 fiscal 2027 earnings loss

Cal-Maine Foods reported a Q1 2027 net loss of $58.6M, down from a $199.3M profit a year earlier, due to lower egg prices and sales. Net sales fell 41.5% to $539.6M. CEO Sherman Miller cited industry overproduction. Shares dropped 3.4% to $66.22. The company settled a price-rigging allegation earlier this year.

$CALMHighAI 8/10

Cal-Maine (CALM) Stock Trades Down, Here Is Why

Cal-Maine Foods (CALM) reported a Q3 2026 net loss, with net sales down 41.5% YoY to $539.6M, missing estimates. Gross profit fell to $403K, and the company posted a net loss of $58.6M. CEO Sherman Miller attributed results to industry supply imbalance. Shares fell 3%, trading at $66.49.

$CALMMedAI 8/10

Cal-Maine Foods Q1 2027 Earnings Call: Complete Transcript - Cal-Maine Foods (NASDAQ:CALM)

Cal-Maine Foods (NASDAQ:CALM) reported Q1 FY2027 net sales down 41.5% to $539.6M and a net loss of $58.6M. The company faces pressure from an oversupplied egg market but is expanding specialty eggs and prepared foods. It plans a 60% increase in prepared foods capacity by H1 FY2028 and has $767.6M in cash. Management repurchased $14.9M in shares post-quarter, focusing on long-term growth.